molab.ai GmbH

Startup

molab.ai provides drug discovery teams with an AI backbone to accelerate and streamline compound optimization. The molab.ai platform delivers highly accurate ADMET property predictions as well as suggestions for novel, alternative molecular structures optimized for improved binding affinity, desirable ADMET properties and synthetic accessibility. molab.ai predictions robustly outperform both physics-based models and alternative AI/ML solutions, provide confidence indicators and, importantly, have been shown to generalize well to novel chemical space. Moreover, molab.ai algorithms are readily usable for the most important ADMET properties as well as common targets and can be adapted with client data, when desired.


             For conference production and speaking opportunites:                          For sponsorship and exhibition opportunities:
                ellie.whitehead@terrapinn.com                                                                                     thomas.hall@terrapinn.com